Amneal Pharmaceuticals, Inc. 4

Ted C. Nark reported the vesting of 34,819 restricted stock units into Class A Common Stock and received a new grant of 19,824 RSUs in Amneal Pharmaceuticals, Inc.

On this Form 4, reporting person Ted C. Nark, an insider of Amneal Pharmaceuticals, Inc., reported routine equity compensation activity consisting of the vesting and conversion of previously granted restricted stock units (RSUs) and a new RSU award. On May 7, 2026, 34,819 RSUs vested and were settled into 34,819 shares of Class A Common Stock at no exercise price, with ownership reported as directly held. Separately, on May 6, 2026, he received a new grant of 19,824 RSUs (each representing one share of Class A Common Stock) at no cost, also reported as directly owned. No open-market purchases or sales were reported, and after these transactions he held 325,848 shares of Class A Common Stock directly, reflecting ongoing equity-based compensation rather than discretionary trading.

Filing Facts

CIK

1723128

Ticker

AMRX

Form

4

Source Type

sec

Accession

0001628280-26-032910

Alert Tier

5